Revisiting the role of factor H in age-related macular degeneration: Insights from complement-mediated renal disease and rare genetic variants

Surv Ophthalmol. 2021 Mar-Apr;66(2):378-401. doi: 10.1016/j.survophthal.2020.10.008. Epub 2020 Nov 4.

Abstract

Ophthalmologists are long familiar with the eye showing signs of systemic disease, but the association between age-related macular degeneration and abnormal complement activation, common to several renal disorders, has only recently been elucidated. Although complement activation products were identified in drusen almost three decades ago, it was not until the early 21st century that a single-nucleotide polymorphism in the complement factor H gene was identified as a major heritable determinant of age-related macular degeneration, galvanizing global efforts to unravel the pathogenesis of this common disease. Advances in proteomic analyses and familial aggregation studies have revealed distinctive clinical phenotypes segregated by the functional effects of common and rare genetic variants on the mature protein and its splice variant, factor H-like protein 1. The predominance of loss-of-function, N-terminal mutations implicate age-related macular degeneration as a disease of general complement dysregulation, offering several therapeutic avenues for its modulation. Here, we explore the molecular impact of these mutations/polymorphisms on the ability of variant factor H/factor H-like protein 1 to localize to polyanions, pentraxins, proinflammatory triggers, and cell surfaces across ocular and renal tissues and exert its multimodal regulatory functions and their clinical implications. Finally, we critically evaluate key therapeutic and diagnostic efforts in this rapidly evolving field.

Keywords: C3 glomerulopathy; age-related macular degeneration; alternative pathway; atypical hemolytic uremic syndrome; complement factor H; complement system; complement therapeutics; genetic variants; pharmacogenomics; subretinal inflammation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Complement Factor H* / genetics
  • Complement Factor H* / metabolism
  • Complement System Proteins / genetics
  • Humans
  • Macular Degeneration* / genetics
  • Phenotype
  • Proteomics

Substances

  • CFH protein, human
  • Complement Factor H
  • Complement System Proteins